In line with the oncogenic role of FXR, Huang et al. observed that FXR promoted cancer cell proliferation, migration, and invasion via modulating CCNE2, a cell cycle regulator, in clear cell renal cell carcinoma (ccRCC) [135]. The gene discussed is NR1H4; the disease is clear cell renal carcinoma.